However, many factors such as the complexity of the tumour microenvironment, unknown mechanisms of the cholesterol metabolic network, individual differences and tumour heterogeneity, challenges in clinical translation, and the complexity of multifactorial interactions may all limit a comprehensive understanding and effective utilisation of CD4+ T cell functions in CRC. The gene discussed is CD4; the disease is neoplasm.